Table 2.
Patient Characteristics by Race
| Percentage of Patients |
|||
|---|---|---|---|
| Characteristic | White, n=1392 |
Black, n=97 |
P * |
| Age, y | .148 | ||
| <50 | 26.9 | 37.1 | |
| 50-59 | 29 | 21.7 | |
| 60-69 | 29.5 | 27.8 | |
| ≥70 | 14.7 | 13.4 | |
| Median (range) | 58.2 (16-86.5) | 55.5 (20.9-80.5) | |
| GOG performance status | .069 | ||
| 0 | 40 | 30.9 | |
| 1 | 49.7 | 52.6 | |
| 2 | 10.3 | 16.5 | |
| Stage/debulking | .482 | ||
| III, microscopic | 19 | 19.6 | |
| III, optimal | 34.3 | 26.8 | |
| III, suboptimal | 31.3 | 36.1 | |
| IV | 15.5 | 17.5 | |
| Tumor grade | .102 | ||
| 1 | 8.7 | 11.3 | |
| 2 | 36.9 | 45.4 | |
| 3 Or not graded | 54.5 | 43.3 | |
| Histology | .052 | ||
| Serous | 72.7 | 77.3 | |
| Endometrioid | 8.6 | 7.2 | |
| Mucinous | 1.8 | 5.2 | |
| Clear cell | 3.2 | 0 | |
| Other | 13.7 | 10.3 | |
GOG indicates Gynecologic Oncology Group.
*
The Pearson chi-square test was used to compare the difference in proportion between the 2 groups.